Skip to main content
OpenTrials

Clinical trial condition

Lung Neoplasms

Explore clinical trials studying Lung Neoplasms. Study availability and eligibility vary by location and protocol.

238 public trials 34 recruiting studies
Refine in advanced search Browse all conditions

Lung Neoplasms trial results

Completed

Study of the Efficacy of an Investigational Drug in Adult Patients With Non Small-Cell Lung Cancer (NSCLC)

NCT00034957

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Research Center Berkeley, California, United States
  • Research Center Greenbrae, California, United States
  • Research Center Los Angeles, California, United States
  • Research Center Rancho Mirage, California, United States
View Trial Details
Completed

Study of Pemetrexed in Mesothelioma and Lung Cancer Patients With Fluid Around the Lungs or Abdomen

NCT00316225

Conditions
Adenoma, Bronchial Neoplasms, Carcinoma, Bronchogenic, +13 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Copenhagen, Denmark
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hanover, Germany
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Madrid, Spain
View Trial Details
Completed

Pulmonart: Docetaxel - Non-Small Cell Lung Cancer (NSCLC)

NCT00174772

Conditions
Lung Diseases, Lung Neoplasms, Neoplasms, +4 more
Locations
  • Sanofi-Aventis Administrative Office Diegem, Belgium
  • Sanofi-Aventis Administrative Office Helsinki, Finland
  • Sanofi-Aventis Administrative Office Paris, France
  • Sanofi-Aventis Administrative Office Milan, Italy
View Trial Details

Related conditions